HPV vaccine manufacturers commited to provide enough supply to immunise at least 84 million girls in Gavi countries
On Jun. 4, 2020, vaccine manufacturers MSD, GSK, Innovax, Serum Institute of India and Walvax pledged to ramp…
On Jun. 4, 2020, vaccine manufacturers MSD, GSK, Innovax, Serum Institute of India and Walvax pledged to ramp…
On Jun. 4, 2020, the U.S. Department of Health and Human Services (HHS) announced new Guidance that specified…
On Jun. 4, 2020, the Bill & Melinda Gates Foundation announced a five-year, US$1.6 billion commitment to Gavi,…
On Jun. 4, 2020, vaccine manufacturers MSD, GSK, Innovax, Serum Institute of India (SII) and Walvax pledged to…
On Jun. 4, 2020, the World Health Organization (WHO) welcomed funding commitments from Gavi, the Vaccine Alliance’s third…
On Jun. 4, 2020, AstraZeneca announced the next steps in its commitment to broad and equitable global access…
On Jun. 4, 2020, the FDA approved Merck’s Recarbrio (a combination of imipenem-cilastatin and relebactam) to treat hospital-acquired…
On Jun. 4, 2020, the WHO announced new pledges that will enable Gavi to protect the next generation…
On Jun. 4, 2020, data from the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the…
On Jun. 4, 2020, Novavax announced that the company had been awarded a contract by the U.S. Department…
On Jun. 4, 2020, Agricultural Research Service scientists and their Oregon State University collaborators announced they had developed…
On Jun. 4, 2020, INOVIO and Seoul National University Hospital announced a partnership to start a Phase 1/2…
On Jun. 4, 2020, iBio announced it had initiatied preclinical immunization studies for its second COVID-19 vaccine platform….
On Jun. 4, 2020, with funding from the Fralin Life Sciences Institute at Virginia Tech, researchers James Weger-Lucarelli…
On Jun. 4, 2020, Roche announced the initiation of a global phase III, randomised, double-blind, multicentre study (REMDACTA)…
On Jun. 3, 2020, in a nationwide study, NIH funded researchers found that the presence of abnormal bundles…
On Jun. 3, 2020, CEPI, the Coalition for Epidemic Preparedness Innovations, in collaboration with Ind-CEPI, announced a new…
On Jun. 2, 2020, the NIH reported that early results showed that remdesivir benefited hospitalized patients with severe…
On Jun. 2, 2020, Agenus announced the FDA’s clearance of AgenTus’ IND application for an allogeneic iNKT therapy….
On Jun. 2, 2020, Pfizer announced the establishment of the Pfizer Breakthrough Growth Initiative, through which Pfizer will…
On Jun. 2, 2020, the USDA announced the first confirmed case of SARS-CoV-2 (the virus that causes COVID-19)…
On Jun. 2, 2020, Albert Einstein College of Medicine announced it had received a $1 million challenge grant…
On Jun. 2, 2020, Trevena announced it had entered into a collaboration with Imperial College London to evaluate…
On Jun. 1, 2020, Resverlogix announced that it is moving forward with a plan to further evaluate apabetaloneメs…
On Jun. 1, 2020, Entos Pharmaceuticals announced a partnership with Cytiva, formerly part of GE Healthcare Life Sciences….
On Jun. 1, 2020, U.S. Dept. of Defense announced it had begun an effort to collect 8,000 donated…
On Jun. 1, 2020, the Government of the Democratic Republic of the Congo announced that a new outbreak…
On Jun. 1, 2020, Gilead Sciences announced topline results from the Phase 3 SIMPLE trial in hospitalized patients…
On Jun. 1, 2020, Emergent BioSolutions announced it had been issued a task order under an existing contract…
On Jun. 1, 2020, Anixa Biosciences and OntoChem announced they had synthesized four potential Covid-19 compounds that will…